Concepedia

Jayme L. Dahlin

JL

35

Publications

2.5K

Citations

20

H-Index

1979

Active since

Affiliations

Brigham and Women's Hospital(Current)

University of Minnesota

National Center for Advancing Translational Sciences

Monash University

National Institutes of Health

Jayme L. Dahlin is an author at Brigham and Women's Hospital specializing in medicine, high-throughput screening, and drug discovery.

Top concepts

MedicineHigh-throughput ScreeningBioanalysisDrug DiscoveryBiochemistryEngineeringAnalytical ChemistryNatural SciencesPharmacologyDrug Analysis

Publications per year

1979–2024

35

Publications

35

The promise and peril of chemical probes

C.H. Arrowsmith, James E. Audia, Christopher P. Austin et al. · Nature Chemical Biology · 2015 · 836 citations · Full text

PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS

Jayme L. Dahlin, J. Willem M. Nissink, Jessica M. Strasser et al. · Journal of Medicinal Chemistry · 2015 · 341 citations · Full text

Lead Compounds, Chemical Mechanisms, Drug Target +23

Assay Guidance Manual [Internet]

Sarine Markossian, A Grossman, Kyle R. Brimacombe et al. · 2004 · 287 citations

Pharmaceutical Research, Drug Target, Biochemistry +15

Cell Viability Assays -- Assay Guidance Manual

Sittampalam Gs, Ashley Grossman, Kyle R. Brimacombe et al. · 2004 · 170 citations

Cell Culture, Cell Manipulation, Cell Viability Assays +4

Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors

Jayme L. Dahlin, Kathryn M. Nelson, Jessica M. Strasser et al. · Nature Communications · 2017 · 105 citations · Full text

Rows per page

1–5 of 35